Endocrinology, Vol 136, 4298-4303, Copyright © 1995 by Endocrine Society

ARTICLES

Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid

S Neuenschwander, CT Roberts Jr and D LeRoith
Section on Molecular and Cellular Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1770, USA.

Insulin-like growth factors (IGFs) play an important role in cellular proliferation, and IGF action appears to be involved in tumorigenesis. To determine the role of the IGF-I receptor in breast cancer cell growth, we stably transfected MCF-7 breast cancer cells with a construct encoding an antisense RNA complementary to the region surrounding the translation initiation site of the IGF-I receptor messenger RNA (mRNA). Control cells were transfected with vector alone. Clones expressing the antisense RNA exhibited a 30% reduction in endogenous IGF-I receptor mRNA levels and a significant reduction in receptor protein levels, as measured by both ligand binding assays and Western blot analysis. Antisense-expressing clones expressed approximately 30,000 receptors/cell compared with approximately 48,000- 58,000 receptors/cell in control (neo) cells (P < 0.05). Although endogenous RNA:RNA hybrids were demonstrable in antisense-expressing cells, our results suggest that the major effect of the antisense may be the reduction in mRNA levels and not via an inhibition of translation. The reduction in receptor expression reduced both IGF-I- and serum-stimulated cellular proliferation. The maximum cell number reached at 96 h in the presence of IGF-I (100 ng/ml) was significantly reduced in antisense-expressing clones (22,000-30,000) compared with that in control (neo) cells (39,000-42,000). Furthermore, IGF-I-induced c-fos gene expression was reduced by 30% in the clones expressing the antisense RNA. These results strongly support a role for the IGF-I receptor in the proliferation of human breast cancer cells and suggest that strategies using this type of technology may prove useful in cancer therapy.

This article has been cited by other articles:

				Y. Kusada, T. Morizono, A. Matsumoto-Takasaki, K. Sakai, S. Sato, H. Asanuma, A. Takayanagi, and Y. Fujita-Yamaguchi Construction and Characterization of Single-chain Antibodies Against Human Insulin-like Growth Factor-I Receptor from Hybridomas Producing 1H7 or 3B7 Monoclonal Antibody J. Biochem., January 1, 2008; 143(1): 9 - 19. [Abstract] [Full Text] [PDF]

				K. L. Gable, B. A. Maddux, C. Penaranda, M. Zavodovskaya, M. J. Campbell, M. Lobo, L. Robinson, S. Schow, J. A. Kerner, I. D. Goldfine, et al. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol. Cancer Ther., April 1, 2006; 5(4): 1079 - 1086. [Abstract] [Full Text] [PDF]

				Y. Wang, J. Hailey, D. Williams, Y. Wang, P. Lipari, M. Malkowski, X. Wang, L. Xie, G. Li, D. Saha, et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody Mol. Cancer Ther., August 1, 2005; 4(8): 1214 - 1221. [Abstract] [Full Text] [PDF]

				Y. H. Ibrahim and D. Yee Insulin-Like Growth Factor-I and Breast Cancer Therapy Clin. Cancer Res., January 15, 2005; 11(2): 944s - 950s. [Abstract] [Full Text] [PDF]

				G. S. Warshamana-Greene, J. Litz, E. Buchdunger, F. Hofmann, C. Garcia-Echeverria, and G. W. Krystal The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling Mol. Cancer Ther., May 1, 2004; 3(5): 527 - 536. [Abstract] [Full Text] [PDF]

				L. Barzon, M. Boscaro, and G. Palu Endocrine Aspects of Cancer Gene Therapy Endocr. Rev., February 1, 2004; 25(1): 1 - 44. [Abstract] [Full Text] [PDF]

				J. Silva, A. Beckedorf, and E. Bieberich Osteoblast-derived Oxysterol Is a Migration-inducing Factor for Human Breast Cancer Cells J. Biol. Chem., July 3, 2003; 278(28): 25376 - 25385. [Abstract] [Full Text] [PDF]

				J. Hailey, E. Maxwell, K. Koukouras, W. R. Bishop, J. A. Pachter, and Y. Wang Neutralizing Anti-Insulin-like Growth Factor Receptor 1 Antibodies Inhibit Receptor Function and Induce Receptor Degradation in Tumor Cells Mol. Cancer Ther., December 1, 2002; 1(14): 1349 - 1353. [Abstract] [Full Text] [PDF]

				P. A. Pennisi, V. Barr, N. P. Nunez, B. Stannard, and D. Le Roith Reduced Expression of Insulin-like Growth Factor I Receptors in MCF-7 Breast Cancer Cells Leads to a More Metastatic Phenotype Cancer Res., November 15, 2002; 62(22): 6529 - 6537. [Abstract] [Full Text] [PDF]

				C L Chernicky, H Tan, L Yi, J R L. de Mola, and J Ilan Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo Mol. Pathol., April 1, 2002; 55(2): 102 - 109. [Abstract] [Full Text] [PDF]

				M. Haimsohn, R. Beery, A. Karasik, H. Kanety, and A. Geier Aurintricarboxylic Acid Induces a Distinct Activation of the IGF-I Receptor Signaling within MDA-231 Cells Endocrinology, March 1, 2002; 143(3): 837 - 845. [Abstract] [Full Text] [PDF]

				M. Bartucci, C. Morelli, L. Mauro, S. Ando', and E. Surmacz Differential Insulin-like Growth Factor I Receptor Signaling and Function in Estrogen Receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 Breast Cancer Cells Cancer Res., September 1, 2001; 61(18): 6747 - 6754. [Abstract] [Full Text] [PDF]

				T. W. Chan, M. Pollak, and H. Huynh Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780 Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554. [Abstract] [Full Text] [PDF]

				K. Reiss, X. Tu, G. Romano, F. Peruzzi, J. Y. Wang, and R. Baserga Intracellular Association of a Mutant Insulin-like Growth Factor Receptor with Endogenous Receptors Clin. Cancer Res., July 1, 2001; 7(7): 2134 - 2144. [Abstract] [Full Text] [PDF]

				V Vella, L Sciacca, G Pandini, R Mineo, S Squatrito, R Vigneri, and A Belfiore The IGF system in thyroid cancer: new concepts Mol. Pathol., June 1, 2001; 54(3): 121 - 124. [Abstract] [Full Text]

				J Dupont and D Le Roith Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects Mol. Pathol., June 1, 2001; 54(3): 149 - 154. [Abstract] [Full Text]

				D. W. Andrews, M. Resnicoff, A. E. Flanders, L. Kenyon, M. Curtis, G. Merli, R. Baserga, G. Iliakis, and R. D. Aiken Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant Astrocytomas J. Clin. Oncol., April 15, 2001; 19(8): 2189 - 2200. [Abstract] [Full Text] [PDF]

				H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF]

				N. Mignet, A. Brun, C. Degert, B. Delord, D. Roux, C. Helene, R. Laversanne, and J.-C. Francois The spherulitesTM: a promising carrier for oligonucleotide delivery Nucleic Acids Res., August 15, 2000; 28(16): 3134 - 3142. [Abstract] [Full Text] [PDF]

				K. Nakamura, A. Hongo, J. Kodama, Y. Miyagi, M. Yoshinouchi, and T. Kudo Down-Regulation of the Insulin-like Growth Factor I Receptor by Antisense RNA Can Reverse the Transformed Phenotype of Human Cervical Cancer Cell Lines Cancer Res., February 1, 2000; 60(3): 760 - 765. [Abstract] [Full Text]

				D. LeRoith Insulin-like Growth Factors in Pediatric Health and Disease J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4355 - 4361. [Full Text]

				K. Tajinda, J. Carroll, and C. T. Roberts Jr. Regulation of Insulin-Like Growth Factor I Receptor Promoter Activity by Wild-Type and Mutant Versions of the WT1 Tumor Suppressor Endocrinology, October 1, 1999; 140(10): 4713 - 4724. [Abstract] [Full Text]

				G. Pandini, R. Vigneri, A. Costantino, F. Frasca, A. Ippolito, Y. Fujita-Yamaguchi, K. Siddle, I. D. Goldfine, and A. Belfiore Insulin and Insulin-like Growth Factor-I (IGF-I) Receptor Overexpression in Breast Cancers Leads to Insulin/IGF-I Hybrid Receptor Overexpression: Evidence for a Second Mechanism of IGF-I Signaling Clin. Cancer Res., July 1, 1999; 5(7): 1935 - 1944. [Abstract] [Full Text] [PDF]

				Z.-D. Xu, L. Oey, S. Mohan, M. H. Kawachi, N.-S. Lee, J. J. Rossi, and Y. Fujita-Yamaguchi Hammerhead Ribozyme-Mediated Cleavage of the Human Insulin-Like Growth Factor-II Ribonucleic Acid in Vitro and in Prostate Cancer Cells Endocrinology, May 1, 1999; 140(5): 2134 - 2144. [Abstract] [Full Text]

				F. Myokai, S. Takashiba, R. Lebo, and S. Amar A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha  gene expression: Molecular cloning, sequencing, characterization, and chromosomal assignment PNAS, April 13, 1999; 96(8): 4518 - 4523. [Abstract] [Full Text] [PDF]

				M. Montagnani Marelli, R. M. Moretti, D. Dondi, M. Motta, and P. Limonta Luteinizing Hormone-Releasing Hormone Agonists Interfere with the Mitogenic Activity of the Insulin-Like Growth Factor System in Androgen-Independent Prostate Cancer Cells Endocrinology, January 1, 1999; 140(1): 329 - 334. [Abstract] [Full Text]

				W. Li, Y.-X. Jiang, J. Zhang, L. Soon, L. Flechner, V. Kapoor, J. H. Pierce, and L.-H. Wang Protein Kinase C-delta Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation Mol. Cell. Biol., October 1, 1998; 18(10): 5888 - 5898. [Abstract] [Full Text]

				W. Zhang, W. H. Thornton Jr., and R. S. MacDonald Insulin-Like Growth Factor-I and II Receptor Expression in Rat Colon Mucosa Are Affected by Dietary Lipid Intake J. Nutr., February 1, 1998; 128(2): 158 - 165. [Abstract] [Full Text]

				C. Hernandez-Sanchez, H. Werner, C. T. Roberts Jr., E. J. Woo, D. W. Hum, S. M. Rosenthal, and D. LeRoith Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor J. Biol. Chem., February 21, 1997; 272(8): 4663 - 4670. [Abstract] [Full Text] [PDF]

				Y. M. Li, D. H. Schacher, Q. Liu, S. Arkins, N. Rebeiz, R. H. McCusker Jr., R. Dantzer, and K. W. Kelley Regulation of Myeloid Growth and Differentiation by the Insulin-Like Growth Factor I Receptor Endocrinology, January 1, 1997; 138(1): 362 - 368. [Abstract] [Full Text] [PDF]

				R. J. Urban and Y. Bodenburg Transcriptional Activation of the Porcine P450 11A Insulin-like Growth Factor Response Element in MCF-7 Breast Cancer Cells J. Biol. Chem., December 6, 1996; 271(49): 31695 - 31698. [Abstract] [Full Text] [PDF]

				J. Dupont, M. Karas, and D. LeRoith The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components J. Biol. Chem., November 10, 2000; 275(46): 35893 - 35901. [Abstract] [Full Text] [PDF]

				P. Sachdev, Y.-X. Jiang, W. Li, T. Miki, H. Maruta, M. S. A. Nur-e-Kamal, and L.-H. Wang Differential Requirement for Rho Family GTPases in an Oncogenic Insulin-like Growth Factor-I Receptor-induced Cell Transformation J. Biol. Chem., July 6, 2001; 276(28): 26461 - 26471. [Abstract] [Full Text] [PDF]